Frontiers in Endocrinology | Cancer Endocrinology

Original Research

Published on 13 Oct 2025

Machine learning algorithms for individualized prediction of prognosis in breast cancer liver metastases and the prognostic impact of primary tumor surgery: a multicenter study

in Cancer Endocrinology

Chunmei Chen
Jundong Wu
Bo Xu
Weiwen Li
Chengming Zhong
Zhibing Yan
Qipeng Zhong
Ronggang Li
Mingtao Shao
Yan Dong

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1656191

540 views

Original Research

Published on 13 Oct 2025

Sustained testosterone suppression: prognostic indicator in advanced hormone sensitive prostate cancer

in Cancer Endocrinology

Dongsheng Ma
Tao Zhuo
Xin Huang
Jianhong Xi

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1652941

621 views

Original Research

Accepted on 10 Oct 2025

Innovative Molecular Targets for Combatting Metastasis in Adrenocortical Carcinoma

in Cancer Endocrinology

Jianqiu Kong
Xiong Chen
Xinxiang Fan
Qihang Zhang
Long Zhang
Chengxiao Liao
Qingqing He
Weibin Xie
Yichun Xing
Junjiong Zheng

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1516467

129 views

Original Research

Published on 08 Oct 2025

GDF15 is associated with thyroid cancer progression and may modulate thyroid cancer cell senescence in a p53-dependent manner

in Cancer Endocrinology

Jingyu Ma
Zishuo Liu
Rui Hua
Changyuan Ding
Zhenpeng Yang
Weili Liang
Bin Lv

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1675245

666 views

Original Research

Accepted on 07 Oct 2025

High Incidence and Poor Prognosis of Bone Metastases in Functioning Small Intestinal Neuroendocrine Tumors

in Cancer Endocrinology

Annie Mathew
Pia Hauptmeier
Schaarschmidt M Benedikt
Wolfgang P Fendler
Dagmar Führer
Harald Lahner

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1680209

Original Research

Published on 06 Oct 2025

Synergistic impact of dysglycemia and HPV on cervical cancer risk: a potential mediating role of Ki-67

in Cancer Endocrinology

Yulong Zhang
Junxin Zhang
Haibo Li
YiLing Zhuang
Qianru You
Yanzhao Su
Xiangqin Zheng
Suyu Li

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1422881

558 views

Original Research

Accepted on 01 Oct 2025

Study of the predictive value of testosterone in androgen deprivation therapy for metastatic hormone sensitive prostate cancer—the dual clinical research centre for western and eastern China

in Cancer Endocrinology

Dongsheng Ma
Xiaoguang Zhang
Jianhong Xi

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1630862

Original Research

Published on 01 Oct 2025

Beyond castration: defining maximal testosterone control in advanced prostate cancer

in Cancer Endocrinology

Dongsheng Ma
Mengru Zhang
Xiaoguang Zhang
Tao Zhuo
Jianhong Xi

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1634966

569 views

Systematic Review

Published on 01 Oct 2025

Initial symptoms and diagnostic delay in immune checkpoint inhibitor-related adrenal insufficiency: a systematic review and meta-ethnography of case reports

in Cancer Endocrinology

Ryuichi Ohta
Yoshinori Ryu
Kaoru Tanaka
Chiaki Sano
Hidetoshi Hayashi

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1636452

734 views

Original Research

Published on 01 Oct 2025

[68Ga]Ga-PSMA-11 PET/CT in medullary thyroid carcinoma: comparison with [18F]FDG PET/CT and immunohistochemical analysis

in Cancer Endocrinology

Klaudia Zajkowska
Elwira Bakuła-Zalewska
Paulina Cegla
Marta Wojewódzka-Mirocha
Paweł Ochman
Agata Sackiewicz
Joanna Januszkiewicz-Caulier
Joanna Długosińska
Małgorzata Czetwertyńska
Marek Dedecjus

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1627500

1,205 views

Original Research

Published on 30 Sep 2025

The diagnostic value of prostate health index combined with soluble e-cadherin for prostate cancer

in Cancer Endocrinology

Yeasin Ahamed
Marofe Hossain
Shantanu Baral
Jing Chen
Weigui Sun

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1531866

872 views

Original Research

Published on 30 Sep 2025

Insights into gastric mixed adenoneuroendocrine carcinoma: a novel comparative study of clinicopathological features and survival outcomes

in Cancer Endocrinology

Huayong Tan
Jing Huang
Gaochun Xiao
Junzhi Liu
Huimin Li
Maojun Di
Yaunjian Hui

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1650314

420 views

Original Research

Published on 29 Sep 2025

Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma

in Cancer Endocrinology

Li Liu
Fang Wei

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1584618

1,931 views

Original Research

Published on 29 Sep 2025

Endoscopic endonasal intradural pituitary transposition for resecting retroinfundibular lesions: technique notes and a single institute experience

in Cancer Endocrinology

Daibo Ke
Shaocheng Yang
Yifeng Lin
Hao Liu
Wei Chen
Tao Lv
Xiang Yue
Ling Xu
Shunwu Xiao

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1547980

1,246 views

Original Research

Published on 29 Sep 2025

Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine Tumors

in Cancer Endocrinology

Erica Pietroluongo
Antonella Lucia Marretta
Mauro Cives
Elisa Andrini
Leonardo Della Sala
Elisabetta Dell’Unto
Alice Carli
Nevena Mikovic
Ilaria Mascagni
Francesco Panzuto

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1687570

1,462 views

Original Research

Published on 23 Sep 2025

Prolactin and DNA damage trigger an anti-breast cancer cell immune response

in Cancer Endocrinology

Ödül Karayazi Atici
Nayantara Govindrajan
Isbel Lopetegui-González
Constance A. M. Finney
Carrie S. Shemanko

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1586062

1,107 views